<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04146857</url>
  </required_header>
  <id_info>
    <org_study_id>NAPOXIA</org_study_id>
    <nct_id>NCT04146857</nct_id>
  </id_info>
  <brief_title>Autonomic Activity During Nap Under Hypoxia</brief_title>
  <acronym>NAPOXIA</acronym>
  <official_title>Effects of Normobaric Hypoxia on Autonomic Activity During a Nap in Healthy Adults (NAPOXIA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sleeping under hypoxic conditions can impair cognition and autonomic nervous activity. A
      short daytime nap can modify these changes. Here we propose a randomized, cross-over study to
      evaluate the heart rate variability during a 90 min nap in a normobaric hypoxic chamber. In
      addition, we will investigate sleep architecture, vigilance, attention and memory.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 30, 2019</start_date>
  <completion_date type="Anticipated">October 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Heart rate variability</measure>
    <time_frame>During 90 minutes nap under normoxic (20.9%) vs. 12.8% hypoxic condition</time_frame>
    <description>Mean RR interval measured by polysomnography (ms)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart rate variability</measure>
    <time_frame>During 90 minutes nap under normoxic (20.9%) vs. 15.0% hypoxic condition</time_frame>
    <description>Mean RR interval measured by polysomnography (ms)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Efficiency (SE)</measure>
    <time_frame>During 90 minutes nap under normoxic (20.9%) vs. two hypoxic conditions (12.8 and 15%)</time_frame>
    <description>Measured by continuous polysomnography (min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wake After Sleep Onset (WASO)</measure>
    <time_frame>During 90 minutes nap under normoxic (20.9%) vs. two hypoxic conditions (12.8 and 15%)</time_frame>
    <description>Measured by continuous polysomnography (min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Onset Latency (SOL)</measure>
    <time_frame>During 90 minutes nap under normoxic (20.9%) vs. two hypoxic conditions (12.8 and 15%)</time_frame>
    <description>Measured by continuous polysomnography (min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Low Frequency / High Frequency Band</measure>
    <time_frame>During 90 minutes nap under normoxic (20.9%) vs. two hypoxic conditions (12.8 and 15%)</time_frame>
    <description>Mean LF/HF ratio measured by continuous ECG</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Standard Deviation 1 / Standard Deviation 2</measure>
    <time_frame>During 90 minutes nap under normoxic (20.9%) vs. two hypoxic conditions (12.8 and 15%)</time_frame>
    <description>Mean SD1/SD2 ratio measured by continuous ECG</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>RR intervals longer than 50 ms</measure>
    <time_frame>During 90 minutes nap under normoxic (20.9%) vs. two hypoxic conditions (12.8 and 15%)</time_frame>
    <description>Percentage pNN50 measured by continuous ECG (%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Core Body Temperature</measure>
    <time_frame>During 90 minutes nap under normoxic (20.9%) vs. two hypoxic conditions (12.8 and 15%)</time_frame>
    <description>Mean temperature measured by continuous double sensor monitoring (°C)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Skin Temperature</measure>
    <time_frame>During 90 minutes nap under normoxic (20.9%) vs. two hypoxic conditions (12.8 and 15%)</time_frame>
    <description>Mean temperature measured by continuous double sensor monitoring (°C)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Digit Span Task</measure>
    <time_frame>After 90 minutes nap under normoxic (20.9%) vs. two hypoxic conditions (12.8 and 15%)</time_frame>
    <description>Longest memorized digit series (n, normal range 5-9, higher is better)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychomotor Vigilance Task Subscale 1</measure>
    <time_frame>After 90 minutes nap under normoxic (20.9%) vs. two hypoxic conditions (12.8 and 15%)</time_frame>
    <description>Number of lapses (normal range 0-6, higher is worse)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychomotor Vigilance Task Subscale 2</measure>
    <time_frame>After 90 min nap under normoxic (20.9%) vs. two hypoxic conditions (12.8 and 15%)</time_frame>
    <description>Mean reaction time (normal range 100-500 ms, higher is worse)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Color Stroope Task Subscale 1</measure>
    <time_frame>After 90 minutes nap under normoxic (20.9%) vs. two hypoxic conditions (12.8 and 15%)</time_frame>
    <description>Number of incongruency errors (normal range 0-5, higher is worse)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Color Stroope Task Subscale 2</measure>
    <time_frame>After 90 minutes nap under normoxic (20.9%) vs. two hypoxic conditions (12.8 and 15%)</time_frame>
    <description>Congruent response time (normal range 400-500 ms, higher is worse)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Color Stroope Task Subscale 3</measure>
    <time_frame>After 90 minutes nap under normoxic (20.9%) vs. two hypoxic conditions (12.8 and 15%)</time_frame>
    <description>Incongruent response time (normal range 600-800 ms, higher is worse)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Color Stroope Task Subscale 4</measure>
    <time_frame>After 90 minutes nap under normoxic (20.9%) vs. two hypoxic conditions (12.8 and 15%)</time_frame>
    <description>Congruent accuracy (above 95% is normal, higher is better)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Color Stroope Task Subscale 5</measure>
    <time_frame>After 90 minutes nap under normoxic (20.9%) vs. two hypoxic conditions (12.8 and 15%)</time_frame>
    <description>Incongruent accuracy (above 85% is normal, higher is better)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Hypoxia</condition>
  <condition>Sleep</condition>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Normoxia</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>20.9% oxygen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hypoxia 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>15.0% oxygen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hypoxia 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>12.8% oxygen</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Normoxia</intervention_name>
    <description>Nap in hypoxia chamber at 20.9% oxygen (36 m asl)</description>
    <arm_group_label>Normoxia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hypoxia 1</intervention_name>
    <description>Nap in hypoxia chamber at 15.0% oxygen (simulates 2660 m asl)</description>
    <arm_group_label>Hypoxia 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hypoxia 2</intervention_name>
    <description>Nap in hypoxia chamber at 12.8% oxygen (simulates 4000 m asl)</description>
    <arm_group_label>Hypoxia 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women

          -  Age 25-45 years

          -  BMI 20 - 28 kg/m^2

        Exclusion Criteria:

          -  Severe, manifest illnesses in need of treatment

          -  Postoperative phases

          -  Acute and chronic infections

          -  Sleep disorders such as sleep apnea, insomnia or somnolence

          -  Altitude exposure (&gt; 2500 m asl) within 6 months before enrollment

          -  Regular migraines

          -  Smoking

          -  Athletes

          -  Significant weight change within 1 month before enrollment

          -  Inability to understand significance and scope of the study

          -  Drug or alcohol abuse
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anja Mähler, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charite University, Berlin, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alain Riveros, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charite University, Berlin, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anja Mähler, PhD</last_name>
    <phone>+49 30 450 540 323</phone>
    <email>anja.maehler@charite.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michael Boschmann, MD</last_name>
    <phone>+49 30 450 540 241</phone>
    <email>michael.boschmann@charite.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Experimental &amp; Clinical Research Center</name>
      <address>
        <city>Berlin</city>
        <zip>13125</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anja Mähler, Dr.</last_name>
      <phone>+49(0)30450540323</phone>
      <email>anja.maehler@charite.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>October 25, 2019</study_first_submitted>
  <study_first_submitted_qc>October 30, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 31, 2019</study_first_posted>
  <last_update_submitted>November 5, 2019</last_update_submitted>
  <last_update_submitted_qc>November 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Anja Maehler</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Hypoxia</keyword>
  <keyword>Sleep</keyword>
  <keyword>Heart rate variability</keyword>
  <keyword>Sleep architecture</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data that underlie the results of reported articles (text, tables, figures, supplemental data) will be shared after deidentification.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>Beginning 9 months and ending 36 months following article publication.</ipd_time_frame>
    <ipd_access_criteria>Researchers who provide a methodologically sound proposal.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

